Stay updated with breaking news from Structure Function Claims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists and federal agencies should redefine what it means to be healthy to substantiate structure-function claims for nutraceuticals, according to a perspective published in the Journal of Dietary Supplements.
Despite language in the 2022 Health Products Compliance Guidance around the need for clinical trials to substantiate health claims, the US Federal Trade Commission has stated that not all claims require that level of substantiation.
A new report titled "Health Claims and Doses of Fish Oil Supplements in the US" that was published in JAMA Cardiology suggests that most fish oil supplement labels make claims about health benefits without trial data to support their efficacy. CRN weighs in.
A new paper in JAMA Cardiology that criticizes the use of structure/function claims on omega-3 dietary supplements is “fraught with inaccuracies and never should have made it through the peer review process”, says the Global Organization for EPA and DHA Omega-3s (GOED).
A new paper in JAMA Cardiology that criticizes the use of structure/function claims on omega-3 dietary supplements is “fraught with inaccuracies and never should have made it through the peer review process”, says the Global Organization for EPA and DHA Omega-3s (GOED).